Calcific Uremic Arteriolopathy Market colloquially known as calciphylaxis, is a rare and life-threatening vascular calcification syndrome. Historically underserved, the market for CUA treatments is currently experiencing a transition toward targeted pharmacological interventions as diagnostic accuracy improves and the global dialysis population expands. https://www.databridgemarketresearch.com/